Sellmer, Andreas’s team published research in European Journal of Medicinal Chemistry in 2020-05-01 | 101083-92-5

European Journal of Medicinal Chemistry published new progress about Acute myeloid leukemia. 101083-92-5 belongs to class indole-building-block, and the molecular formula is C7H5N3O2, Reference of 101083-92-5.

Sellmer, Andreas; Pilsl, Bernadette; Beyer, Mandy; Pongratz, Herwig; Wirth, Lukas; Elz, Sigurd; Dove, Stefan; Henninger, Sven Julian; Spiekermann, Karsten; Polzer, Harald; Klaeger, Susan; Kuster, Bernhard; Boehmer, Frank D.; Fiebig, Heinz-Herbert; Kraemer, Oliver H.; Mahboobi, Siavosh published the artcile< A series of novel aryl-methanone derivatives as inhibitors of FMS-like tyrosine kinase 3 (FLT3) in FLT3-ITD-positive acute myeloid leukemia>, Reference of 101083-92-5, the main research area is aryl methanone preparation FLT3 tyrosine kinase inhibitor antitumor human; Acute myeloid leukemia; FLT3; FLT3 D835Y; FLT3-ITD; Tyrosine kinase inhibitor.

Mutants of the FLT3 receptor tyrosine kinase (RTK) with duplications in the juxtamembrane domain (FLT3-ITD) act as drivers of acute myeloid leukemia (AML). Potent tyrosine kinase inhibitors (TKi) of FLT3-ITD entered clin. trials and showed a promising, but transient success due to the occurrence of secondary drug-resistant AML clones. A further caveat of drugs targeting FLT3-ITD is the co-targeting of other RTKs which are required for normal hematopoiesis. This is observed quite frequently. Therefore, novel drugs are necessary to treat AML effectively and safely. Recently bis(1H-indol-2-yl)methanones were found to inhibit FLT3 and PDGFR kinases. In order to optimize these agents novel derivatives of these methanones with various substituents were synthesized. Methanone I and its carbamate derivative II inhibit FLT3-ITD at least as potently as the TKi AC220 (quizartinib). Models indicate corresponding interactions of I and quizartinib with FLT3. The activity of I is accompanied by a high selectivity for FLT3-ITD.

European Journal of Medicinal Chemistry published new progress about Acute myeloid leukemia. 101083-92-5 belongs to class indole-building-block, and the molecular formula is C7H5N3O2, Reference of 101083-92-5.

Referemce:
Indole alkaloid derivatives as building blocks of natural products from Bacillus thuringiensis and Bacillus velezensis and their antibacterial and antifungal activity study,
Preparation of Indole Containing Building Blocks for the Regiospecific Construction of Indole Appended Pyrazoles and Pyrroles